MULTIPLE-MYELOMA TREATED WITH HIGH-DOSE INTRAVENOUS MELPHALAN

被引:239
|
作者
SELBY, PJ
MCELWAIN, TJ
NANDI, AC
PERREN, TJ
POWLES, RL
TILLYER, CR
OSBORNE, RJ
SLEVIN, ML
MALPAS, JS
机构
[1] ROYAL MARSDEN HOSP,MED SECT,SUTTON SM2 5PT,SURREY,ENGLAND
[2] ST BARTHOLOMEWS HOSP,ICRF DEPT MED ONCOL,LONDON EC1A 7BE,ENGLAND
[3] HACKNEY HOSP,LONDON,ENGLAND
关键词
D O I
10.1111/j.1365-2141.1987.tb06890.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:55 / 62
页数:8
相关论文
共 50 条
  • [11] HIGH-DOSE MELPHALAN WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR MULTIPLE-MYELOMA
    BARLOGIE, B
    HALL, R
    ZANDER, A
    DICKE, K
    ALEXANIAN, R
    [J]. BLOOD, 1986, 67 (05) : 1298 - 1301
  • [12] HIGH-DOSE MELPHALAN IS NOT ASSOCIATED WITH EXTRAMEDULLARY RELAPSES IN HIGH-RISK MULTIPLE-MYELOMA
    MOREAU, P
    BATAILLE, R
    MAHE, B
    MILPIED, N
    HAROUSSEAU, JL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (09) : 1832 - 1832
  • [13] INTERMITTENT HIGH-DOSE MELPHALAN PREDNISONE VS CONTINUOUS LOW-DOSE MELPHALAN TREATMENT IN MULTIPLE-MYELOMA
    AHRE, A
    BJORKHOLM, M
    MELLSTEDT, H
    HOLM, G
    BRENNING, G
    ENGSTEDT, L
    GAHRTON, G
    HALLEN, J
    JOHANSSON, B
    JOHANSSON, SGO
    KARNSTROM, L
    KILLANDER, A
    LERNER, R
    LOCKNER, D
    LONNQVIST, B
    SIMONSSON, B
    STALFELT, AM
    TERNSTEDT, B
    WADMAN, B
    [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (04): : 499 - 506
  • [14] ASCT and high-dose melphalan in multiple myeloma
    Sharma, Sharan Prakash
    [J]. LANCET ONCOLOGY, 2014, 15 (11): : E481 - E481
  • [15] High-dose melphalan in patients with multiple myeloma
    Moreau, P
    Le Bonniec, M
    Harousseau, JL
    [J]. BULLETIN DU CANCER, 1999, 86 (03) : 283 - 288
  • [16] RESULTS OF ORAL AND INTRAVENOUS MELPHALAN IN MULTIPLE-MYELOMA
    ILLIGER, HJ
    HARTLAPP, JH
    SCHMIDT, RE
    [J]. TUMORDIAGNOSTIK & THERAPIE, 1984, 5 (05) : 182 - 185
  • [17] PHARMACOLOGY OF INTRAVENOUS MELPHALAN IN PATIENTS WITH MULTIPLE-MYELOMA
    BROX, L
    BIRKETT, L
    BELCH, A
    [J]. CANCER TREATMENT REVIEWS, 1979, 6 : 27 - 32
  • [18] VAMP FOLLOWED BY HIGH-DOSE MELPHALAN AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR MULTIPLE-MYELOMA
    MCELWAIN, TJ
    GORE, ME
    MELDRUM, M
    VINER, C
    JUDSON, IR
    MALPAS, JS
    [J]. BONE MARROW TRANSPLANTATION, 1989, 4 : 109 - 112
  • [19] IDIOTYPIC IMMUNOGLOBULIN AS AN INDICATOR OF RESIDUAL DISEASE IN MULTIPLE-MYELOMA FOLLOWING TREATMENT WITH HIGH-DOSE MELPHALAN
    THOMPSON, J
    SELBY, P
    ANDERSON, V
    MCELWAIN, TJ
    STEVENSON, GT
    [J]. BRITISH JOURNAL OF CANCER, 1987, 55 (03) : 345 - 345
  • [20] HIGH-DOSE MELPHALAN FOR MULTIPLE-MYELOMA - LONG-TERM FOLLOW-UP DATA
    CUNNINGHAM, D
    PAZARES, L
    GORE, ME
    MALPAS, J
    HICKISH, T
    NICOLSON, M
    MELDRUM, M
    VINER, C
    MILAN, S
    SELBY, PJ
    NORMAN, A
    RAYMOND, J
    POWLES, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (04) : 764 - 768